Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice

Area of Science:

• Cardiovascular Disease Research
• Metabolic Disorders
• Molecular Biology

Background:

• Cardiovascular disease is the primary cause of death in diabetic patients.
• Diabetic cardiomyopathy presents as cardiac morphological and functional changes, unrelated to hypertension or coronary artery disease.
• The precise molecular mechanisms connecting diabetes to cardiomyopathy remain unclear.

Purpose of the Study:

• To investigate the role of FoxO proteins in the development of diabetic cardiomyopathy.
• To explore FoxO proteins as potential therapeutic targets for diabetic heart disease.

Main Methods:

• Induction of diabetes in mice using genetic models or a high-fat diet (HFD).
• Assessment of cardiac function and morphology in diabetic mouse models.
• Analysis of FoxO protein activation and its downstream effects in cardiac tissue.
• Conditional deletion of FoxO1 in cardiomyocytes to evaluate its specific role.

Main Results:

• FoxO proteins were found to be consistently activated in the cardiac tissue of diabetic mice.
• Cardiomyocyte-specific deletion of FoxO1 prevented cardiac dysfunction and preserved insulin responsiveness in HFD-induced diabetes.
• FoxO1 depletion led to a metabolic shift from fatty acids to glucose in cardiomyocytes, reducing cardiac lipid accumulation.
• FoxO1-dependent downregulation of IRS1 was observed, leading to impaired Akt signaling and insulin resistance.

Conclusions:

• Persistent activation of FoxO1 is a key mediator in the pathogenesis of diabetic cardiomyopathy.
• Targeting FoxO1 activation presents a promising therapeutic strategy for treating diabetic cardiomyopathy and improving cardiovascular outcomes in diabetic patients.